Skip to content

Public FDA record

Z-0037-2025: The EPIONE device v1.0.2 is a user controlled, stereotactic accessory device intended to assist in the pl

Recall record Z-0037-2025 for QUANTUM SURGICAL SAS. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0037-2025
Company in FDA record
QUANTUM SURGICAL SAS
FDA classification date
Oct 9, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Quantum Surgical has become aware that a component (central axis) inside the Needle Guide product (product number 02-0027) is the subject of rust.

Source facts

Action
Quantum Surgical issued an URGENT FIELD SAFETY NOTICE to its sole consignee via visit on 08/05/2024 and followed up with an email on 08/19/2024. The notice explained the problem, potential risk, and requested that the consignee cease use of the device. The affected units were returned, repaired, and replaced.
Initiated
2024-08-05
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution in the state of FL.
Recall number
Z-0037-2025
Recall status
Completed
CDRH record ID
209707
FDA classified
2024-10-09
Recall event number
95194

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗